<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: This study explored the correlation between duration of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in spontaneously hypertensive rats as a measure of outcome after neuroprotective intervention </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We used 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining to discriminate infarcted tissue and calculate <z:mpath ids='MPATH_124'>infarct</z:mpath> volume 24 hours after temporary tandem common carotid/middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> lasting 5 to 150 minutes </plain></SENT>
<SENT sid="2" pm="."><plain>We used a graded bioassay described by logistic function and executed by computer program (ALLFIT) to evaluate changes in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after increasing durations of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The method allowed us to calculate the maximal <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (Volmax) and the duration of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> before reperfusion producing half-maximal <z:mpath ids='MPATH_124'>infarct</z:mpath> size (T50) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0002045'>Hypothermia</z:hpo> and the <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi> <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-1102 begun after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> were tested for their ability to reduce Volmax and prolong T50 as analyzed by ALLFIT </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Volmax was 180.6 +/- 22.4 mm3 and T50 was 45.9 +/- 5.8 minutes in control rats </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002045'>Hypothermia</z:hpo> (30 degrees C) applied during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> reduced Volmax by 66 mm3 and extended T50 by 50% (P &lt; .05 for each comparison) </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-1102, like <z:hpo ids='HP_0002045'>hypothermia</z:hpo>, extended T50 by 44% but did not have an effect on Volmax </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Analysis of the changes of <z:mpath ids='MPATH_124'>infarct</z:mpath> size after increasing durations of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> indicates that although both were protective, the two treatments tested may exhibit different profiles of efficacy </plain></SENT>
<SENT sid="9" pm="."><plain>This method of analyzing <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced damage may be very sensitive for studying the efficacy and possible clinical use of neuronal protective therapies for hyperacute <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>